Back
Royal Bank of Canada Vs. ANI Pharmaceuticals Industry Stock Comparison
Buy
65
RY
Royal Bank of Canada
Last Price:
123.05
Seasonality Move:
2.76%
Buy
53
ANIP
ANI Pharmaceuticals
Last Price:
60.79
Seasonality Move:
0.29%
Buy
65
Royal Bank of Canada (RY)
is a Buy
Is Royal Bank of Canada a Buy, Sell or Hold?
- The current Royal Bank of Canada [RY] share price is $122.56. The Score for RY is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
- RY is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
53
ANI Pharmaceuticals (ANIP)
is a Buy
Is ANI Pharmaceuticals a Buy, Sell or Hold?
- The current ANI Pharmaceuticals [ANIP] share price is $61.05. The Score for ANIP is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
- ANIP is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
RY Stock Price Chart
What is Royal Bank of Canada's stock price today?
-
The Royal Bank of Canada share price today is $122.56
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RY is experiencing slight selling pressure.
ANIP Stock Price Chart
What is ANI Pharmaceuticals's stock price today?
-
The ANI Pharmaceuticals share price today is $61.05
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ANIP is experiencing slight selling pressure.
RY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.97 | Buy |
| Relative Strength Index (14 RSI): | 69.06 | Buy |
| Chaikin Money Flow: | -209910 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (113.84 - 123.04) | Buy |
| Bollinger Bands (100): | (103.02 - 115.96) | Buy |
ANIP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.84 | Sell |
| Relative Strength Index (14 RSI): | 52.65 | Buy |
| Chaikin Money Flow: | -163397 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (57.84 - 62.92) | Buy |
| Bollinger Bands (100): | (59.73 - 65.45) | Sell |
RY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 123.1 | Sell |
| 20-day SMA: | 120.14 | Buy |
| 50-day SMA: | 114.18 | Buy |
| 200-day SMA: | 103.93 | Buy |
| 8-day EMA: | 122.61 | Sell |
| 20-day EMA: | 120.09 | Buy |
| 50-day EMA: | 115.32 | Buy |
| 200-day EMA: | 105.54 | Buy |
ANIP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 57.54 | Buy |
| 20-day SMA: | 60.34 | Buy |
| 50-day SMA: | 61.2 | Sell |
| 200-day SMA: | 61.23 | Sell |
| 8-day EMA: | 58.88 | Buy |
| 20-day EMA: | 59.62 | Buy |
| 50-day EMA: | 60.85 | Buy |
| 200-day EMA: | 60.54 | Buy |
Royal Bank of Canada Earnings Growth & RY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.18 per share, an increase next quarter of $0.18 per share, an increase this year of $0.64 per share, and an increase next year of $0.55 per share.
ANI Pharmaceuticals Earnings Growth & ANIP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.25 per share, an increase next quarter of $0.40 per share, an increase this year of $0.29 per share, and an increase next year of $0.99 per share.
Royal Bank of Canada Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
ANI Pharmaceuticals Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||